HIV treatment

Topics in this section

HIV treatment: latest news

HIV treatment resources

HIV treatment features

HIV treatment in your own words

HIV treatment news from aidsmap

More news

HIV treatment news selected from other sources

  • 13th International workshop on Clinical Pharmacology of HIV Therapy 16–18 April 2012, Barcelona

    This important annual workshop always includes studies that are not presented to other meetings.

    3 hours ago | i-base

  • Rwanda: HIV Mortality Rate Down to 5 Percent

    Rwanda's HIV mortality rate has reduced to 5 per cent compared to 7 per cent two years ago.

    3 hours ago | AllAfrica

  • UGANDA: Rising ARV resistance threatens HIV fight

    The prevalence of drug-resistant HIV strains in Uganda has risen from 8.6 percent to 12 percent in the last five years, one of the highest rates in Sub-Saharan Africa, according to a recent study.

    23 hours ago | IRIN Plus News

  • Broad-Spectrum Antivirals: The Future of HIV Treatment?

    Could a single drug be used to treat a variety of viruses -- potentially all viruses, including HIV? At least three novel approaches are being worked on to create such a drug, also known as a broad-spectrum antiviral.

    17 May 2012 | The Body

  • Doubt Cast on the ‘Good’ in ‘Good Cholesterol’

    A study in the Lancet that makes use of powerful databases of genetic information has found that raising the levels of high-density lipoprotein HDL, the so-called 'good' cholesterol, may not reduce heart disease risk as was thought.

    17 May 2012 | New York Times

  • Slim Abdool Karim: Shaking up SA’s ailing medical research

    Hand-picked for the job by Health Minister Aaron Motsoaledi, Karim is used to difficult challenges. He was a political activist and medical student at the height of apartheid and went on to become one of the world’s leading HIV researchers, investigating vaginal gels to protect women from infection.

    11 May 2012 | Business Day

  • Report Outlines HIV Cure Research, Important Gaps

    Three HIV/AIDS activist groups convened a meeting in March with researchers and representatives of the U.S. Food and Drug Administration (FDA) to describe the current state of cure research and identify barriers to moving such research forward swiftly and smoothly. The proceedings of this meeting, which took place immediately before the 19th Conference on Retroviruses and Opportunistic Infections (CROI) that began on March 5 in Seattle, are now available in a report online.

    26 April 2012 | AIDSMeds

  • Genetic testing for drug intolerance

    Intolerance to a drug is something most people learn about themselves only after it's prescribed. "There are some tumour drugs, for certain cancers, that 70% of the population won't respond to. For some asthma drugs, it's 40%," says Dingermann, who has been collecting research on the topic for the past four years.

    16 April 2012 | The Guardian

  • CROI: Crofelemer Reduces Diarrhea in People with HIV; FDA Grants Priority Review

    A plant compound known as crofelemer significantly decreased the frequency of secretory diarrhea in HIV positive patients, researchers reported at the 19th Conference on Retroviruses and Opportunistic Infections (CROI 2012) last month in Seattle. The U.S. Food and Drug Administration (FDA) has given crofelemer priority review status and is expected to take action by early June.

    13 April 2012 | HIVandHepatitis.com

  • Can I Get A Witness! Authentic Voices Tell the Story of Neuropathy

    Authors, scientists, doctors, journalists and bloggers can write about neuropathy until they're blue in the face but there's no substitute for hearing people tell their own stories. This post is therefore given over to some of the men and women with both HIV and Neuropathy who have opened their hearts on forums and in blogs across the Net. There are many, many more!

    12 April 2012 | The Body
More news

Our information levels explained

  • Short and simple introductions to key HIV topics, sometimes illustrated with pictures.
  • Expands on the previous level, but also written in easy-to-understand plain language.
  • More detailed information, likely to include medical and scientific language.
  • Detailed, comprehensive information, using medical and specialised language.

See also